期刊文献+

盐酸利多卡因纳米高分子脂质体的制备与体外透皮实验研究 被引量:3

Preparation of Lidocaine Hydrochloride-loaded Polymeric Liposomes and Permeation through Mouse Skin in Vitro
下载PDF
导出
摘要 目的采用赖氨酸壳聚糖十八烷基季铵盐(OQLCS)/胆固醇包载盐酸利多卡因制备纳米高分子脂质体(LID-PLs),并研究其体外透皮渗透情况。方法采用反相蒸发法制备LID-PLs和盐酸利多卡因传统脂质体(LID-CLs),用激光粒度仪/Zeta电位仪测试其粒径;建立测定盐酸利多卡因浓度的HPLC法;使用离体小鼠皮和Franz扩散池进行体外透皮实验,评价不同时间点LID-PLs、LID-CLs和盐酸利多卡因注射液(LID-IJ)的体外透皮渗透情况。结果 LID-PLs组粒径小于LID-CLs组[(61.2±8.14)nmvs(219±7.51)nm]。所建立的HPLC法专一性好,盐酸利多卡因的保留时间为3.899min,空白纳米高分子脂质体、空白透皮接收液对盐酸利多卡因的测定均无影响,其标准曲线方程为=0.051X-2.701(r=0.9999)。LID-PLs组在5min、10min、30min、2h、4h、6h、8h、12h及24h的平均累积透过量均明显高于LID-CLs组和LID-IJ组(P<0.05或P<0.01)。LID-CLs组在10min、30min、1.5h、2h、4h、6h、8h、12h、24h的平均累积透过量均明显高于LID-IJ组(P<0.05或P<0.01)。结论 LID-PLs制备简单,具有良好的透皮释放行为,所建立的HPLC方法准确可靠。 Objective To prepare the lidocaine hydrochloride-loaded lysine modified chitosan polymeric liposomes (LID-PLs) and to study its permeation characteristics through mouse skin in vitro. Methods LID-PLs and lidocaine hydrochloride-loaded conventional liposomes (LID-CLs) were prepared by reverse-phase evaporation method. The diameter and zeta potential of LID-PLs and LID-CLs were determined by dynamic light scattering (DLS) using a Brookhaven Zetasizer. A HPLC method of determination of lidoeaine hydroehloride was established. The isolated mouse skin and Franz diffusion cells were used to evaluate the permeation characteristics of LID-PLs, LID-CLs and lidocaine hydrochloride injection (LID-H). Results The diameter of LID-PLs was significantly smaller than that of LID-CLs (61.2±8.14 nm vs 219±7.51 am). The A specificity of HPLC was high and the standard curve equation was y=0.05 lX-2.701, r=0.999 9. The mean cumulative permeation of lidocaine was significantly higher at 5 min,10 min, 30 rain, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h after administration in LID-PLs group than those in LID-CLs group and LID-H group (P 〈 0.05 or P 〈 0.01). The mean cumulative permeation of lidocaine was significantly higher in LID-CLs group than that in LID-IJ group at 10 rain, 30 min, 1.5 h, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h after administration (P 〈 0.05 or P 〈 0.01). Conclusion The preparation of LID-PLs is simple and it has good permeation in vitro. The HPLC method is accurate and reliable.
出处 《天津医药》 CAS 北大核心 2013年第4期341-344,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(项目编号:81070871) 天津市自然科学基金重点资助项目(项目编号:11JCZDJC20400)
关键词 盐酸利多卡因 纳米结构 脂质体 壳聚糖 赖氨酸 药物利用 体外研究 lidocaine hydrochloride nanostructures liposomes chitosan lysine drug utilization in vitro
  • 相关文献

参考文献4

二级参考文献62

  • 1边佳明,赵维娟,许景峰.国外经皮给药系统的研究进展[J].中国药房,2005,16(14):1112-1114. 被引量:21
  • 2赵鹏,张本恕,肖颖,孔屏,孙峰.盐酸司来吉兰治疗早期帕金森病的疗效观察[J].临床神经病学杂志,2005,18(4):306-307. 被引量:9
  • 3董炎明,阮永红,赵雅青,毕丹霞,杨柳林,葛强.N-烷基壳聚糖玻璃化转变温度的研究[J].物理化学学报,2005,21(11):1307-1310. 被引量:5
  • 4Postma T J, Helmans J J, Luykx SA, et al. A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma [J]. Ann Oncol, 2000. 11(4) :409-413.
  • 5Marupudi N I, Han J E, Li K W, et al. Paelitaxel:a review of adverse toxicities and novel delivery strategies [J]. Expert Opin Drug Saf, 2007, 6(5) :609-621.
  • 6Glantz M J, Choy H, Kearns C M, et al. Paelitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors [J]. J Natl Cancer Inst, 1995, 19;87(14):1077- 1081.
  • 7Liang X F, Wang H J, Luo H, et al. Characterization of novel multifunctional cationic polymeric liposomes formed from octa- decyl quateruized carboxymethyl chitosao/cholesterol and drug encapsulation [J]. Langmuir, 2008, 24:7147-7153.
  • 8Wiegand S, Heinen T, Ramaswamy A, et al. Evaluation of the tolerance and distribution of intravenously applied ferrofluid particles of 250 and 500 nm size in an animal model [J]. J Drug Target, 2008, 17:1.
  • 9Mitra S, Gaur U, Ghosh P C, et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanopartieles as carrier [J]. J Control Release, 2001, 74 (1- 3) :317-323.
  • 10Liebmann J E, Cook J A, Lipschultz C, et al. Cytotoxic stud- ies of paclitaxel (Taxol) in human tumour cell lines [J]. Br J Cancer, 1993, 68(6) :1104-1109.

共引文献26

同被引文献34

  • 1杨莉.透皮贴剂的研究进展与临床应用[J].继续医学教育,2006,20(28):82-85. 被引量:5
  • 2中国药典[S].2010年版.一部.39-40,189,32.
  • 3张晓璐,戴夕娣,丁建.高效液相色谱法测定复方吲哚美辛乳膏中吲哚美辛的含量[J].药物分析杂志,2007,27(8):1269-1270. 被引量:10
  • 4Desai P,Patlolla RR,Singh M.Interaction of nanoparticles andcell-penetrating peptides with skin for transdermal drug delivery[J].Mol Membr Biol,2010,27(7):247-259.doi:10.3109/09687688.2010.522203.
  • 5Basse LH,Groen D,Bouwstra JA,et al.Permeability and lipid orga-nization of a novel psoriasis stratum corneum substitute[J].Int J Pharm,2013,457(1):275-282.doi:10.1016/j.ijpharm.2013.08.086.
  • 6Groen D,Poole DS,Gooris GS,et al.Is an orthorhombic lateral pack-ing and a proper lamellar organization important for the skin barri-er function[J]?Biochim Biophys Acta,2011,1808(6):1529-1537.
  • 7Subongkot T,Pamornpathomkul B,Rojanarata T,et al.Investigation ofthe mechanism of enhanced skin penetration by ultradeformable li-posomes[J].Int J Nanomedicine,2014,25(9):3539-3550.doi:10.2147/IJN.S65287.
  • 8Wang S,Zeng D,Niu J,et al.Development of an efficient transder-mal drug delivery system with TAT-conjugated cationic polymericlipid vesicles[J].J Mater Chem B,2014,2:877-884.doi:10.1039/c3tb21353f.
  • 9Zhou QL,Chen ZY,Wang YX,et al.Ultrasound-mediated localdrug and gene delivery using nanocarriers[J].Bio Med Res Int,2014,2014:963891.doi:10.1155/2014/963891.
  • 10Kraft JC,Freeling JP,Wang Z,et al.Emerging research and clinicaldevelopment trends of liposome and lipid nanoparticle drug deliverysystems[J].J Pharm Sci,2014,103(1):29-52.doi:10.1002/jps.23773.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部